as on February 26, 2026 at 9:31 pm IST
Day's Low
Day's High
1.83%
Downside
2.34%
Upside
52 Week's Low
52 Week's High
49.08%
Downside
36.12%
Upside
as on February 26, 2026 at 4:01 pm IST
Market Cap
₹228.41 Cr
Return on Equity (ROE)
1.24
PE Ratio (TTM)
0Return on capital employed (ROCE)
2.99
Beta (LTM)
0.76
P/B Ratio
2.42
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
8.33
EPS (TTM)
0Sector
Healthcare
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Lotus Eye with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 228.41 | 43.49% | 0.00 | 2 | 49 | |
| NA | 882.97 | 1.43% | 0.64 | 9 | 40 | |
| NA | 14.48 | 10.38% | 0.00 | -2 | 4 | |
| NA | 17.93 | -15.95% | 0.00 | -45 | 7 | |
| NA | 882.61 | 27.97% | 0.00 | 20 | 186 |
Search interest for Lotus Eye Hospital & Institute Ltd Stock has increased by 103% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:103% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Lotus Eye.
Lotus Eye Hospital & Institute Ltd’s net profit fell -8.33% since last year same period to ₹0.26Cr in the Q3 2025-2026. On a quarterly growth basis, Lotus Eye Hospital & Institute Ltd has generated -316.67% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2023, Lotus Eye Hospital & Institute Ltd has declared dividend of ₹0.50 per share on 24 May 2023 - translating a dividend yield of 0.91%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
![]()
Foreign Institutions have increased holdings from 0.00% to 0.01% in Dec 2025 quarter
Best in 1 Year
![]()
In the last 1 year, LOTUSEYE has outperformed top 5 stocks with highest market-cap in Healthcare Facilities & Services
Promoter Holding Up
![]()
Promoters have increased holdings from 40.64% to 40.67% in Dec 2025 quarter
Against Peers
![]()
In the last 3 years, Fortis Healthcare Ltd has given 250.3% return, outperforming this stock by 180.6%
Retail Holding Down
![]()
Retail Investor have decreased holdings from 59.33% to 59.31% in Dec 2025 quarter
Price Dip
![]()
In the last 7 days, LOTUSEYE stock has moved down by -11.2%
| Organisation | Lotus Eye Hospital & Institute Ltd |
| Industry | Healthcare |
| CEO | Kaveetha Sundaramoorthy |
| E-voting on shares | Click here to vote |
Lotus Eye share price today stands at ₹107.99 as on at the close of the market. Lotus Eye share today touched a day high of ₹110.52 and a low of ₹106.01.
Lotus Eye touched a 52 week high of ₹147 and a 52 week low of ₹54.99. Lotus Eye share price today i.e. is closed at ₹107.99, which is -26.54% down from its 52 week high and 96.38% up from its 52 week low.
Lotus Eye market capitalisation is ₹228.41 Cr as on .
To buy Lotus Eye shares, you need to follow these steps:
Lotus Eye trading volume is 14.90K as on . This means that 14.90K shares of Lotus Eye were bought and sold on the stock market during today's trading session.